An update on the treatment options for gout and calcium pyrophosphate deposition

被引：10

作者：

Choy, G ^{[1
]}

机构：

[1] Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Div Rheumatol, Toronto, ON M4N 3M5, Canada

来源：

EXPERT OPINION ON PHARMACOTHERAPY | 2005年 / 6卷 / 14期

关键词：

calcium pyrophosphate; chondrocalcinosis; crystal arthritis; gout; hyperuricaemia;

D O I：

10.1517/14656566.6.14.2443

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Gout and calcium pyrophosphate deposition disease are two common causes of inflammatory joint disease. Despite differences underlying their pathogenesis, their clinical presentation and treatment share some common features. Optimal treatment for both requires prompt resolution of acute synovitis, reduction of chronic joint damage and management of associated conditions. Available therapeutic interventions and future strategies are reviewed in this article.

引用

页码：2443 / 2453

页数：11

共 101 条

[21]

Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4

[22] Cross-sectional study of 50 patients with calcium pyrophosphate dihydrate crystal arthropathy [J].

Canhao, H ;

Fonseca, JE ;

Leandro, MJ ;

Romeu, JC ;

Pimentao, JB ;

Costa, JT ;

Queiroz, MV .

CLINICAL RHEUMATOLOGY, 2001, 20 (02) :119-122

[23] A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis [J].

Cheng, TT ;

Lai, HM ;

Chiu, CK ;

Chen, YC .

CLINICAL THERAPEUTICS, 2004, 26 (03) :399-406

[24] Calcium crystal effects on the cells of the joint: implications for pathogenesis of disease [J].

Cheung, HS .

CURRENT OPINION IN RHEUMATOLOGY, 2000, 12 (03) :223-227

[25] Purine-rich foods, dairy and protein intake, and the risk of gout in men [J].

Choi, HK ;

Atkinson, K ;

Karlson, EW ;

Willett, W ;

Curhan, G .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (11) :1093-1103

[26] Chondrocalcinosis and Gitelman's syndrome.: A new association? [J].

Cobeta-Garcia, JC ;

Gascón, A ;

Iglesias, E ;

Estopinán, V .

ANNALS OF THE RHEUMATIC DISEASES, 1998, 57 (12) :748-749

[27] Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of Hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma:: Results of the GRAAL1 [J].

Coiffier, B ;

Mounier, N ;

Bologna, S ;

Fermé, C ;

Tilly, H ;

Sonet, A ;

Christian, B ;

Casasnovas, O ;

Jourdan, E ;

Belhadj, K ;

Herbrecht, R .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) :4402-4406

[28] Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study [J].

Dessein, PH ;

Shipton, EA ;

Stanwix, AE ;

Joffe, BI ;

Ramokgadi, J .

ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 (07) :539-543

[29]

EBERL R, 1983, ARZNEIMITTEL-FORSCH, V33-1, P641

[30]

ELASY T, 1995, WESTERN J MED, V162, P360

← 1 2 3 4 5 6 7 8 9 10 →